Corerx
Clearwater, US · Florida corporation · 1 known investors
Biotech
Founders & leadership
RL
RONALD L MILLERDirector, Promoter
MJ
MARK J LICARDEExecutive Officer, Director, Promoter
BM
BRIAN MCMILLANExecutive Officer, Director, Promoter
TR
TODD R DAVIAUExecutive Officer, Director, Promoter
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3MraisedMar 2019 · PharmaceuticalsRule 506(b)
▶$3MraisedMar 2019 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- TODD R DAVIAUExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Mar 2019
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$5MraisedApr 2017 · 3 investors · PharmaceuticalsRule 506(b)
▶$5MraisedApr 2017 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- TODD DAVIAUExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $500K
- First sale
- Mar 2017
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$7MraisedMar 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$7MraisedMar 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- RONALD L MILLERDirector, Promoter
- MARK J LICARDEExecutive Officer, Director, Promoter
- BRIAN MCMILLANExecutive Officer, Director, Promoter
- TODD R DAVIAUExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $7M
- Sales commissions
- $125K
- Proceeds to insiders
- $966.6K
- Placement agents
- STILLPOINT CAPITAL LLC
- First sale
- Mar 2015
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.